Andere talen Dong Sung Bio Pharm.Co.,Ltd.

Aandelen

A002210

KR7002210003

slotkoers Korea S.E. Andere beurzen 00:00:00 27-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5.150 ^KRW	0,00%		-0,77%	-10,59%

2022	Dong Sung Bio Pharm.Co.,Ltd. (KOSE:A002210) kondigt een Equity Buyback aan voor 261.780 aandelen.	CI
2022	Dong Sung Bio Pharm.Co.,Ltd. keurt een Buyback Plan goed.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding	24-07-23
Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding	20-07-23
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on June 23, 2022, has expired.	23-09-22
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on June 23, 2022.	24-08-22
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 261,780 shares.	23-06-22
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	23-06-22
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on August 20, 2021, has expired.	19-11-21
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on August 20, 2021.	07-10-21
Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 8.5 billion in funding from a group of investors	23-08-21
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 209,424 shares.	20-08-21
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	20-08-21
Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 8.5 billion in funding from a group of investors	13-08-21
Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback announced on March 19, 2020, has expired.	19-06-20
Tranche Update on Dong Sung Bio Pharm.Co.,Ltd.'s Equity Buyback Plan announced on March 19, 2020.	21-04-20
Dong Sung Bio Pharm.Co.,Ltd. announces an Equity Buyback for 233,918 shares.	19-03-20
Dong Sung Bio Pharm.Co.,Ltd. authorizes a Buyback Plan.	19-03-20
Dong Sung Bio Pharm.Co.,Ltd.(KOSE:A002210) added to S&P Global BMI Index	24-09-18
Dongsung Pharmaceutical Co.,Ltd announced that it has received KRW 24 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm and other investors	16-04-18
Dongsung Pharmaceutical Co.,Ltd announced that it expects to receive KRW 24 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm and other investors.	09-04-18
Dongsung Pharmaceutical Co. Ltd. announced that it has received KRW 10 billion in funding from Synergy Partners Co., Ltd., Golden Bridge Asset Management Co., Ltd., Susung Asset Management Co., Ltd., NH Investment & Securities Co., Ltd., Investment Arm	12-07-16

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Dong Sung Bio Pharm.Co.,Ltd.

Aandelen

A002210

KR7002210003

Andere talen

Filters